Clinical trial
Olanzapine Versus Placebo in the Treatment of Mania in Adolescents With Bipolar…
NCT00050206 · Eli Lilly and Company, Industry · Completed
Key facts
| NCT number | NCT00050206 |
|---|---|
| Title | Olanzapine Versus Placebo in the Treatment of Mania in Adolescents With Bipolar I Disorder |
| Official title | Olanzapine Versus Placebo in the Treatment of Mania in Adolescents With Bipolar I Disorder |
| Lead sponsor | Eli Lilly and Company, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Bipolar Disorder |
| Intervention type | Drug |
| Interventions | Olanzapine, Placebo |
| Enrollment | 130 |
| Start date | Nov 1, 2002 |
| Completion | May 1, 2005 |
| First posted | Nov 27, 2002 |
| Last update posted | Jun 12, 2007 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: